General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
BMJ Case Rep. 2021 May 24;14(5):e240387. doi: 10.1136/bcr-2020-240387.
Tenofovir disoproxil fumarate (TDF) is an antiretroviral drug widely used as a first-line treatment of hepatitis B virus (HBV) and HIV. Increasing evidence has emerged associating its use with the development of Fanconi syndrome, renal insufficiency and bone disease. We report a case of a 61-year-old woman with a remote history of liver transplant for cirrhosis due to HBV. Over 1 year, the patient had recurrent falls, generalised myalgias and arthralgias, misdiagnosed as fibromyalgia. We discuss a complication of her transplant treatment regimen with the drug TDF leading to a rare but reversible disorder: tenofovir-induced Fanconi osteomalacia with renal phosphate wasting. Though recognised, this rare disorder was initially likely missed due to clinical unfamiliarity with the diagnosis, concomitant psychiatric symptoms and premature diagnostic closure.
富马酸替诺福韦二吡呋酯(TDF)是一种抗逆转录病毒药物,被广泛用作治疗乙型肝炎病毒(HBV)和 HIV 的一线药物。越来越多的证据表明,其使用与 Fanconi 综合征、肾功能不全和骨疾病的发展有关。我们报告了一例 61 岁女性,因 HBV 导致肝硬化行肝移植。1 年多来,患者反复跌倒,全身肌肉疼痛和关节疼痛,误诊为纤维肌痛。我们讨论了她的移植治疗方案中药物 TDF 导致的一种罕见但可逆转的疾病:替诺福韦诱导的 Fanconi 骨软化症伴肾磷酸盐丢失。尽管这种罕见的疾病已被认识到,但由于对诊断不熟悉、同时存在精神症状和过早的诊断结束,最初可能被漏诊。